Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1845-1845
Open Access | Times Cited: 25

Showing 25 citing articles:

Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report
Valentina Lombardo, Giuseppa Scandurra, Angela Pettinato, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Similarities in Mechanisms of Ovarian Cancer Metastasis and Brain Glioblastoma Multiforme Invasion Suggest Common Therapeutic Targets
G. G. Jackson, David Cory Adamson
Cells (2025) Vol. 14, Iss. 3, pp. 171-171
Open Access
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications
Sneha Basu, Revathy Nadhan, Danny N. Dhanasekaran
Cancers (2025) Vol. 17, Iss. 3, pp. 472-472
Open Access
Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors
Ieva Vaicekauskaitė, Paulina Kazlauskaitė, Rugilė Gineikaitė, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 441-441
Open Access
Human epidermal growth factor receptor 3 expression in patients with epithelial ovarian cancer: a potential target for ovarian mucinous and clear cell carcinoma
Sho Sato, Daisuke Shintani, Yuki Kaneda, et al.
International Journal of Clinical Oncology (2025)
Closed Access
Molecular Crosstalk by miR-449a and miR-34b in endometrial and ovarian cancer cells in vitro
Anuradha Sharma, Hanisha, Ashwani K. Rana, et al.
Gene (2025) Vol. 947, pp. 149337-149337
Closed Access
Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer
Han Wu, Jialin Zhang, Qiujie Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Beyond the BRCA1/2 genes in ovarian cancer: the role of germline pathogenic variants in the ATM gene
Daniele Guadagnolo, Angelo Minucci, Antonella Chiavassa, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
Valentina Glueck, Christoph Grimm, Magdalena Postl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 786-786
Open Access
Ultrasensitive Electrochemical Diagnostic Platform for Dual Cancer Biomarkers Using a Disposable Sheet@Polymer Nanocomposite-Based Screen-Printed Electrode
Hema Bhardwaj, Ashok Sharma, Pratima R. Solanki
ACS Applied Polymer Materials (2025)
Closed Access
Heritable genetic Variability in ovarian Tumours: Exploring venous thromboembolism susceptibility and cancer prognosis in a Hospital-Based study
Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, et al.
Gene (2025) Vol. 950, pp. 149378-149378
Closed Access
Few-Layer Graphene-Based Optical Nanobiosensors for the Early-Stage Detection of Ovarian Cancer Using Liquid Biopsy and an Active Learning Strategy
Obdulia Covarrubias‐Zambrano, Deepesh Agarwal, Joan Lewis-Wambi, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 375-375
Open Access
Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour
Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2356-2356
Open Access | Times Cited: 3
Advances in Dendritic Systems and Dendronized Nanoparticles: Paradigm Shifts in Cancer Targeted Therapy and Diagnostics
Pawan Kedar, Apeksha Saraf, Rahul Maheshwari, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 28-57
Closed Access | Times Cited: 2
The Transformative Role of Nanoenzymes in the Diagnosis, Targeted Treatment, and Prognosis of Ovarian Cancer. A comprehensive review
Ahmed Imran, Aqsa Gulzar, Muhammad Rehman Gulzar, et al.
Developmental medico-life-sciences (2024) Vol. 1, Iss. 10, pp. 4-22
Closed Access | Times Cited: 1
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
Alexander Olawaiye, Jae‐Weon Kim, Andrea Bagaméri, et al.
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 4
Open Access
Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian Cancer
Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 928-928
Open Access
Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems
Qianhan Lin, Jiajia Li, Zulimire Abudousalamu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9351-9370
Open Access
Investigating the Prevalence and Risk Determinants of Ovarian Cancer in Women from Bauchi State North-East, Nigeria
Murtala Muhammad Jibril, Maryam Dalhatu Baffah, Mohammed B. Mohammed
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update
Marios A. Diamantopoulos, Panagiotis G. Adamopoulos, Andreas Scorilas
Expert Review of Molecular Diagnostics (2024), pp. 1-17
Closed Access
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer
Sa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11733-11733
Open Access
Integrative multi-omics and machine learning approach reveals tumor microenvironment-associated prognostic biomarkers in ovarian cancer
Wenzhi Jiao, Shasha Yang, Yue Li, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 11, pp. 6182-6200
Open Access
Production of novel peptide‐targeting antibodies for anti‐Müllerian hormone receptor 2 and induction of cytotoxicity in ovarian cancer cells
Çağrı Şakalar, Büşra Kurt, Sedat Sezen, et al.
Scandinavian Journal of Immunology (2024) Vol. 101, Iss. 1
Closed Access
Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes
Inês Guerra de Melo, Valéria Tavares, Joana Savva-Bordalo, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1630-1630
Open Access
Cytotoxic Activity of Curcumin- and Resveratrol-Loaded Core–Shell Systems in Resistant and Sensitive Human Ovarian Cancer Cells
Joanna Weżgowiec, Zofia Łapińska, Łukasz Lamch, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 41-41
Open Access
Page 1

Scroll to top